A new study focusing on the common CA-125 blood test found that some patients were 23 percent less likely to show elevated ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

Charlotte Elwood was diagnosed with a rare ovarian cancer in 1997 and given six months to live. She received multiple ...

In a study on ovarian cancer cells, researchers from Karolinska Institutet demonstrate how the tumor environment influences ...

Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients ...

An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at ...

Two unique Hudson Institute research projects have been chosen among eight nationally to share in the largest-ever funding ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

An Assembly committee approved a bill requiring health insurers to increase coverage for ovarian cancer screenings during a ...

Researchers found that Black and Native American patients were 23% less likely to have high levels of CA-125 when diagnosed ...

The cancer antigen (CA)-125 test may miss ovarian cancer in some Black and Native American patients, delaying their treatment ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to ...